Patra, Nabanita <br/><br/>
A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.  [electronic resource] 

 -  European journal of pharmacology  May 2011 
 - 98-107 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2011.02.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--chemical synthesis<br/>Apoptosis--drug effects<br/>Biocatalysis--drug effects<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>DNA Topoisomerases, Type II--metabolism<br/>Down-Regulation--drug effects<br/>Flavonoids--chemical synthesis<br/>Free Radical Scavengers--chemical synthesis<br/>Humans<br/>Male<br/>Molsidomine--analogs & derivatives<br/>Oxidative Stress--drug effects<br/>Prostatic Neoplasms--metabolism<br/>Reactive Oxygen Species--metabolism<br/>Topoisomerase II Inhibitors--chemical synthesis<br/>Tumor Suppressor Protein p53--metabolism<br/>Up-Regulation--drug effects